- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03253783
The Evaluation of Pulse: A Mobile Health App and Teen Pregnancy Prevention Program
This study uses a randomized controlled design to evaluate the efficacy of a new mobile app, Pulse, in reducing the incidence of unprotected sex among young women. Pulse is a web-based mobile health application that can be accessed through mobile smartphones and computers. Pulse was designed to increase highly effective birth control use and reproductive and sexual health care utilization, and ultimately decrease teen pregnancy. The sample is comprised of women with the following characteristics at study enrollment: aged 18-20, not pregnant or trying to become pregnant, has daily access to a smartphone, currently living in the United States or a U.S. territory, and speaks either English or Spanish. Most of the sample (at least 70%) will be women who identify as Black and/or Latina. The evaluation team plans to enroll up to 1,300 participants over a one-year enrollment period using social media, including Facebook, Instagram, and Twitter.
Users access Pulse autonomously, on their own terms, and in their own time and place. The app consists of 6 sections and includes 3 hours of unique content. It does not require the user to follow a specific sequence of content viewed; however, all users will receive a monetary incentive after registering with the apps. Youth randomized to the intervention condition are given access to Pulse indefinitely and receive daily text messages related to sexual health for 6 weeks. Control participants are directed to a free general health/fitness web-based mobile application, also called Pulse, and receive text messages related to general health for 6 weeks. The control and treatment apps look and feel similar aesthetically but contain different content. Participants in both the intervention and comparison groups receive a baseline survey and a 6-week follow-up survey. Participants will also receive incentives once they complete the baseline and post-intervention survey. Both surveys are conducted online via an electronic survey platform. This study is being conducted as a Rigorous Evaluation of New or Innovative Approaches to Prevent Teen Pregnancy funded by the U.S. Department of Health and Human Services' Office of Adolescent Health.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21202
- Healthy Teen Network
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Gender: Female
- Age Limit: 18-20
- Must have daily access to a smartphone that receives text messages and can access to the Internet
- Must speak English or Spanish
- Must live in the United States or a U.S. territory
Exclusion Criteria:
- Currently pregnant or trying to get pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Unprotected sex, no contraceptive
Time Frame: 6-week post-baseline (in the past 6 weeks)
|
Ever having sexual intercourse without using any method of contraception (among full sample)
|
6-week post-baseline (in the past 6 weeks)
|
|
Unprotected sex, no highly effective contraceptive
Time Frame: 6-week post-baseline (in the past 6 weeks)
|
Ever having sexual intercourse without using a hormonal or LARC method of contraception (among full sample)
|
6-week post-baseline (in the past 6 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reproductive and sexual health care utilization (among full sample)
Time Frame: 6-weeks post-baseline
|
Visiting a health care provider for reproductive or sexual health services within the past 6 weeks for the 1st follow-up survey
|
6-weeks post-baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Genevieve Martinez-Garcia, PhD, Healthy Teen Network
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- TP2AH000038
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraceptive Usage
-
Texas Christian UniversityOklahoma State UniversityNot yet recruiting
-
Hospices Civils de LyonRecruitingContraceptive UsageFrance
-
JhpiegoCompleted
-
University of ChicagoCompleted
-
Texas Christian UniversityRecruiting
-
Karolinska InstitutetRecruitingContraceptive UsageSweden
-
The University of Texas at San AntonioEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
Assiut UniversityCompleted
-
Nemours Children's ClinicMerck Sharp & Dohme LLCWithdrawnContraceptive Usage
-
BayerCompletedContraceptive UsageUnited States, Spain, Netherlands, Canada
Clinical Trials on Pulse
-
Children's Mercy Hospital Kansas CityBaylor University; University of Missouri, Kansas City; LifespanCompletedHypoxia | BronchiolitisUnited States
-
Amplitude Vascular Systems, Inc.RecruitingCoronary Arterial Disease (CAD)New Zealand, Australia
-
Amplitude Vascular Systems, Inc.Active, not recruitingPeripheral Arterial Disease (PAD)United States
-
University of Colorado, BoulderEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMultiple SclerosisUnited States
-
The First Affiliated Hospital with Nanjing Medical...CompletedRosacea | Pulsed Dye LaserChina
-
GE HealthcareCompletedClinical Indication for a Head MRIUnited States
-
William Beaumont HospitalsCompletedAsthma in Children | Respiratory Disease | Bronchiolitis Acute | Pneumonia in ChildrenUnited States
-
University of CopenhagenKU LeuvenCompleted
-
The Second Affiliated Hospital of Dalian Medical...Recruiting
-
Cairo UniversityCompletedDiabetic Retinopathy | Macula EdemaEgypt